EuroAPI Header EuroAPI Header

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find the latest news about Alexion Pharmaceuticals aggregated by PharmaCompass.com.

    Client Virtual Booth

    ALEXION PHARMACEUTICALS

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Formulations

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Alexion Pharmaceuticals
    United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    352 Knotter Drive Cheshire, CT 06410
    Telephone
    Telephone
    203-272-ALXN (2596)
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://alexion.com/
    Linkedin
    Linkedin
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    left grey arrow
    right gray arrow
    Full View ScreenFull Screen View
    Alexion Pharma's Biologic Kanuma (sebelipase alfa) Receives Approval in US
    Alexion Pharma's Biologic Kanuma (sebelipase alfa) Receives Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125561

    FDA
    10 Jul 2024
    Share Share
    Alexion Pharma's Biologic Strensiq (asfotase alfa) Receives Approval in US
    Alexion Pharma's Biologic Strensiq (asfotase alfa) Receives Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125513

    FDA
    10 Jul 2024
    Share Share
    Alexion's Biologic Ultomiris (ravulizumab-cwvz) Receives Approvals in the US
    Alexion's Biologic Ultomiris (ravulizumab-cwvz) Receives Approvals in the US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761108

    FDA
    28 Jun 2024
    Share Share
    Alexion Pharma's Biologic Soliris (exulizumab) Receives Approval in US
    Alexion Pharma's Biologic Soliris (exulizumab) Receives Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125166

    FDA
    28 Jun 2024
    Share Share
    US FDA approves Amgen's biosimilar to AZ's rare blood disorder treatment
    US FDA approves Amgen's biosimilar to AZ's rare blood disorder treatment

    https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-amgens-biosimilar-astrazenecas-rare-blood-disorder-treatment-2024-05-28/

    REUTERS
    29 May 2024
    Share Share
    Astrazeneca Amyloidosis Commitment: 2024 Isa Symposium Data Presented
    Astrazeneca Amyloidosis Commitment: 2024 Isa Symposium Data Presented

    https://www.businesswire.com/news/home/20240523803476/en

    BUSINESSWIRE
    23 May 2024
    Share Share
    Monte Rosa’s $100M offering; Alexion to hand back preclinical program to Zealand
    Monte Rosa’s $100M offering; Alexion to hand back preclinical program to Zealand

    https://endpts.com/monte-rosas-100m-offering-alexion-to-hand-back-preclinical-program-to-zealand-pharma/

    ENDPTS
    16 May 2024
    Share Share
    AZ's Alexion debuts short film highlighting NMOSD community
    AZ's Alexion debuts short film highlighting NMOSD community

    https://www.fiercepharma.com/marketing/astrazenecas-alexion-takes-nmosd-awareness-campaign-long-form-new-film-highlighting

    Andrea Park FIERCE PHARMA
    18 Apr 2024
    Share Share
    Lights, camera and community: AZ’s Alexion creates an original film
    Lights, camera and community: AZ’s Alexion creates an original film

    https://endpts.com/lights-camera-and-community-astrazenecas-alexion-creates-an-original-film-to-spotlight-rare-neurological-disorder/

    Beth Snyder Bulik FIERCE BIOTECH
    11 Apr 2024
    Share Share
    Onco360 Has Selected as the Sole National Specialty Pharmacy Partner for Voydeya
    Onco360 Has Selected as the Sole National Specialty Pharmacy Partner for Voydeya

    https://www.globenewswire.com/news-release/2024/04/08/2859605/0/en/Onco360-Has-Been-Selected-as-the-Sole-National-Specialty-Pharmacy-Partner-for-Voydeya-danicopan.html

    GLOBENEWSWIRE
    08 Apr 2024
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    aspen-api-m-2024-08-19

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search